Journal
/
/
Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
JoVE Journal
Immunology and Infection
A subscription to JoVE is required to view this content.  Sign in or start your free trial.
JoVE Journal Immunology and Infection
Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
DOI:

12:55 min

February 16, 2015

, , , , ,

Chapters

  • 00:05Title
  • 01:59Administration of Temozolomide and Whole Brain Irradiation to Tumor-bearing Mice (days 0-4)
  • 03:26Cell Transfection, Splenectomy, and T Cell Preparation (day 0)
  • 06:09Transduction (days 1 and 2)
  • 08:10CAR T Cell and Administration to Tumor-bearing Mice (days 3-5)
  • 10:03Results: Antitumor Efficacy of CAR T Cells
  • 11:47Conclusion

Summary

Automatic Translation

The lymphodepletive and immunomodulatory effects of chemotherapy and radiation standard of care can be leveraged to enhance the antitumor efficacy of T cell immunotherapy. We outline a method for generating EGFRvIII-specific chimeric antigen receptor (CAR) T cells and administering them in the context of glioblastoma standard of care.

Related Videos

Read Article